Creating a Health Utility Value for Birdshot Chorioretinopathy

被引:2
|
作者
Sekaran, Anisha [1 ,2 ]
Shamdas, Mohith [1 ,2 ]
Barry, Robert J. [1 ,2 ]
Denniston, Alastair K. [1 ,2 ,3 ]
Murray, Philip, I [1 ,2 ]
机构
[1] Univ Birmingham, Acad Unit Ophthalmol, Coll Med & Dent Sci, Inst Inflammat & Ageing, Birmingham, W Midlands, England
[2] Sandwell & West Birmingham Hosp NHS Trust, bBirmingham & Midland Eye Ctr, Birmingham, W Midlands, England
[3] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp Birmingham, Dept Ophthalmol, Birmingham, W Midlands, England
关键词
Birdshot chorioretinopathy; quality of life; time trade-off; standard gamble; EQ-5D-5L; NEI VFQ-25; QUALITY-OF-LIFE; TIME TRADE-OFF; STANDARD GAMBLE; IMPACT;
D O I
10.1080/09273948.2020.1799034
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To create a health utility value for birdshot chorioretinopathy (BCR) using Time Trade-Off (TTO) and Standard Gamble (SG) utilities. Method Adult BCR patients completed TTO, SG, EQ-5D-5L, and NEI VFQ-25 questionnaires and underwent a detailed history and clinical examination. Results A total of 28 BCR patients (9 M, 19 F; mean age 62 years, range 47-83) were included. There were 22 patients with a logMAR vision of 0.3 or better in both eyes. Mean TTO was 0.90 +/- SD 0.18 (range 0.33-1.0) and mean SG was 0.94 +/- SD 0.14 (range 0.5-1.0). TTO correlated with EQ-5D-5L index value (p= .024) and NEI VFQ-25 composite score (p= .015). Conclusions Of 28 patients with BCR, 11 would trade remaining life (mean 5.4 years), and 6 would take a risk of immediate death (mean 28% risk), in return for perfect vision in both eyes for the rest of their life.
引用
收藏
页码:73 / 80
页数:8
相关论文
共 50 条
  • [1] Creating a Health Utility Value for Birdshot Chorioretinopathy
    Sekaran, Anisha
    Shamdas, Mohith
    Barry, Robert John
    Denniston, Alastair K.
    Murray, Philip Ian
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [2] Birdshot chorioretinopathy
    Shao, Emily H.
    Menezo, Victor
    Taylor, Simon R. J.
    [J]. CURRENT OPINION IN OPHTHALMOLOGY, 2014, 25 (06) : 488 - 494
  • [3] Birdshot chorioretinopathy
    Monnet, Dominique
    Brezin, Antoine P.
    [J]. CURRENT OPINION IN OPHTHALMOLOGY, 2006, 17 (06) : 545 - 550
  • [4] Birdshot Chorioretinopathy
    Cunningham, Emmett T., Jr.
    Levinson, Ralph D.
    Denniston, Alastair K.
    Brezin, Antoine P.
    Zierhut, Manfred
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2017, 25 (05) : 589 - 593
  • [5] Birdshot chorioretinopathy
    Shah, KH
    Levinson, RD
    Yu, F
    Goldhardt, R
    Gordon, LK
    Gonzales, CR
    Heckenlively, JR
    Kappel, PJ
    Holland, GN
    [J]. SURVEY OF OPHTHALMOLOGY, 2005, 50 (06) : 519 - 541
  • [6] Birdshot chorioretinopathy
    Harun, S
    Clearkin, LG
    [J]. OPHTHALMOLOGY, 2005, 112 (03) : 527 - 528
  • [7] The pathogenesis of birdshot chorioretinopathy
    Holak, Heinrich M.
    Szymaniec, Stanislaw
    Holak, Sophie A.
    [J]. SURVEY OF OPHTHALMOLOGY, 2006, 51 (04) : 446 - 447
  • [8] Birdshot chorioretinopathy - Reply
    Rothova, A
    Baarsma, GS
    [J]. OPHTHALMOLOGY, 2005, 112 (03) : 528 - 528
  • [9] Birdshot Chorioretinopathy: A Review
    Bousquet, Elodie
    Duraffour, Pierre
    Debillon, Louis
    Somisetty, Swathi
    Monnet, Dominique
    Brezin, Antoine P.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (16)
  • [10] COMPLICATIONS IN BIRDSHOT CHORIORETINOPATHY
    PRIEM, HA
    OOSTERHUIS, JA
    [J]. INTERNATIONAL OPHTHALMOLOGY, 1987, 11 (02) : 122 - 122